Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Carcinoma, Hepatocellular 9Neoplasms 7Neoplasm Metastasis 5Carcinoma, Non-Small-Cell Lung 5Recurrence 4Prostatic Neoplasms 4Melanoma 4Breast Neoplasms 4Lymphoma, B-Cell, Marginal Zone 3Lymphoma 3Head and Neck Neoplasms 3Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Polycystic Ovary Syndrome 2Pleural Effusion, Malignant 2Mesothelioma, Malignant 2Leukemia, Lymphocytic, Chronic, B-Cell 2Anxiety Disorders 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Rare Malignant Neoplasm 1Pancreatic Neoplasms 1Neuroblastoma 1Nephrotic Syndrome 1Neoplasms, Plasma Cell 1NSCLC 1Myeloproliferative Disorders 1Multiple Myeloma 1

Interventions

Cyclophosphamide 83Peripheral Blood Stem Cell Transplantation 76fludarabine phosphate 74Busulfan 60Cyclosporine 57Imatinib Mesylate 50Mycophenolic Acid 49Antilymphocyte Serum 48Tacrolimus 44Radiotherapy 44Filgrastim 43Methotrexate 39Whole-Body Irradiation 34Dasatinib 34Methylprednisolone 30Cord Blood Stem Cell Transplantation 26nilotinib 25Melphalan 24Cytarabine 23Interferon-alpha 22Etoposide 20sargramostim 19Flow Cytometry 13Therapeutics 11Cyclosporins 11Sirolimus 10Polymerase Chain Reaction 10bosutinib 9Thiotepa 9Hydroxyurea 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myeloid, Chronic-Phase × Pharmaceutical Preparations × Clear all
NCT03817398 2026-05-20

Stopping Tyrosine Kinase Inhibitors in Affecting Treatment-Free Remission in Patients With Chronic Phase Chronic Myeloid Leukemia

Children's Oncology Group

Phase 2 Active not recruiting
110 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Chronic-Phase

Data powered by HemOnc (CC BY 4.0) Colophon âš¡